References analysis of the Wikipedia article "Prostate cancer" in the English version

cancer.org

doi.org

Rebello et al. 2021, "Figure 3: Prostate cancer stages and progression.". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Rebello et al. 2021, "Epidemiology". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Merriel, Funston & Hamilton 2018, "Symptoms and signs". Merriel SW, Funston G, Hamilton W (September 2018). "Prostate Cancer in Primary Care". Adv Ther. 35 (9): 1285–1294. doi:10.1007/s12325-018-0766-1. PMC 6133140. PMID 30097885.

Rebello et al. 2021, "Figure 3: Prostate cancer stages and progression". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Coleman et al. 2020, "Prevalence of SREs". Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, et al. (October 2020). "Bone Metastases". Nat Rev Dis Primers. 6 (1): 83. doi:10.1038/s41572-020-00216-3. hdl:20.500.11820/6bac9e59-0afa-4b4a-bebf-4e747b889917. PMID 33060614. S2CID 222350837.

Coleman et al. 2020, "Prostate cancer". Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, et al. (October 2020). "Bone Metastases". Nat Rev Dis Primers. 6 (1): 83. doi:10.1038/s41572-020-00216-3. hdl:20.500.11820/6bac9e59-0afa-4b4a-bebf-4e747b889917. PMID 33060614. S2CID 222350837.

Rebello et al. 2021, "Screening and early detection". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Carlsson & Vickers 2020, "3. Tailor screening frequency based on PSA-level". Carlsson SV, Vickers AJ (November 2020). "Screening for Prostate Cancer". Med Clin North Am. 104 (6): 1051–1062. doi:10.1016/j.mcna.2020.08.007. PMC 8287565. PMID 33099450.

Carlsson & Vickers 2020, "4. For men with elevated PSA (≥3 ng/mL), repeat PSA.". Carlsson SV, Vickers AJ (November 2020). "Screening for Prostate Cancer". Med Clin North Am. 104 (6): 1051–1062. doi:10.1016/j.mcna.2020.08.007. PMC 8287565. PMID 33099450.

Duffy 2020, "Percent free PSA". Duffy MJ (February 2020). "Biomarkers for Prostate Cancer: Prostate-Specific Antigen and Beyond". Clin Chem Lab Med. 58 (3): 326–339. doi:10.1515/cclm-2019-0693. PMID 31714881.

Duffy 2020, "Prostate Health Index (PHI)". Duffy MJ (February 2020). "Biomarkers for Prostate Cancer: Prostate-Specific Antigen and Beyond". Clin Chem Lab Med. 58 (3): 326–339. doi:10.1515/cclm-2019-0693. PMID 31714881.

Duffy 2020, "4K score". Duffy MJ (February 2020). "Biomarkers for Prostate Cancer: Prostate-Specific Antigen and Beyond". Clin Chem Lab Med. 58 (3): 326–339. doi:10.1515/cclm-2019-0693. PMID 31714881.

Duffy 2020, Table 2. Duffy MJ (February 2020). "Biomarkers for Prostate Cancer: Prostate-Specific Antigen and Beyond". Clin Chem Lab Med. 58 (3): 326–339. doi:10.1515/cclm-2019-0693. PMID 31714881.

Rebello et al. 2021, "Box 1: Screening for prostate cancer in different regions". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Rebello et al. 2021, "Diagnosis". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Maffei, Giganti & Moore 2023, "MRI as a test for clinically referred men with a raised PSA or abnormal digital rectal exam. Maffei D, Giganti F, Moore CM (February 2023). "Seminar: Revisiting the Value of PSA-Based Prostate Cancer Screening Essay No 5: Should Men Undergo MRI Before Prostate Biopsy? (Pro)". Urol Oncol. 41 (2): 88–91. doi:10.1016/j.urolonc.2022.04.016. PMID 35871993.

Epstein 2018, "Historical background", "2005 and 2014 ISUP grading conferences", and "Gleason patterns". Epstein JI (January 2018). "Prostate Cancer Grading: a Decade After the 2005 Modified System". Mod Pathol. 31 (S1): S47–63. doi:10.1038/modpathol.2017.133. PMID 29297487.

Rebello et al. 2021, "Management". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Liu et al. 2021, "Reclassification and progression". Liu JL, Patel HD, Haney NM, Epstein JI, Partin AW (April 2021). "Advances in the Selection of Patients with Prostate Cancer for Active Surveillance". Nat Rev Urol. 18 (4): 197–208. doi:10.1038/s41585-021-00432-w. PMID 33623103. S2CID 232024016.

Liu et al. 2021, "Abstract". Liu JL, Patel HD, Haney NM, Epstein JI, Partin AW (April 2021). "Advances in the Selection of Patients with Prostate Cancer for Active Surveillance". Nat Rev Urol. 18 (4): 197–208. doi:10.1038/s41585-021-00432-w. PMID 33623103. S2CID 232024016.

Rebello et al. 2021, "Localized Disease". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Costello 2020, "The rise of robotic surgery". Costello AJ (March 2020). "Considering the Role of Radical Prostatectomy in 21st Century Prostate Cancer Care". Nat Rev Urol. 17 (3): 177–188. doi:10.1038/s41585-020-0287-y. PMID 32086498. S2CID 211234353.

Rebello et al. 2021, "Biochemical recurrence and residual disease". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Rebello et al. 2021, "Biocehmical recurrence and residual disease". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Rebello et al. 2021, "Metastatic hormone-sensitive prostate cancer". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Achard et al. 2022, "Introduction". Achard V, Putora PM, Omlin A, Zilli T, Fischer S (2022). "Metastatic Prostate Cancer: Treatment Options". Oncology. 100 (1): 48–59. doi:10.1159/000519861. PMID 34781285. S2CID 244132770.

Rebello et al. 2021, "Metastatic castration-resistant prostate cancer". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Teo, Rathkopf & Kantoff 2019, "Management of metastatic castration-resistant prostate cancer". Teo MY, Rathkopf DE, Kantoff P (January 2019). "Treatment of Advanced Prostate Cancer". Annu Rev Med. 70: 479–499. doi:10.1146/annurev-med-051517-011947. PMC 6441973. PMID 30691365.

Teo, Rathkopf & Kantoff 2019, "Abiraterone acetate". Teo MY, Rathkopf DE, Kantoff P (January 2019). "Treatment of Advanced Prostate Cancer". Annu Rev Med. 70: 479–499. doi:10.1146/annurev-med-051517-011947. PMC 6441973. PMID 30691365.

Coleman et al. 2020, "Prevalence of bone metastases". Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, et al. (October 2020). "Bone Metastases". Nat Rev Dis Primers. 6 (1): 83. doi:10.1038/s41572-020-00216-3. hdl:20.500.11820/6bac9e59-0afa-4b4a-bebf-4e747b889917. PMID 33060614. S2CID 222350837.

Coleman et al. 2020, "Analgesics used in CIBP". Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, et al. (October 2020). "Bone Metastases". Nat Rev Dis Primers. 6 (1): 83. doi:10.1038/s41572-020-00216-3. hdl:20.500.11820/6bac9e59-0afa-4b4a-bebf-4e747b889917. PMID 33060614. S2CID 222350837.

Thompson, Wood & Feuer 2007, "Cord compression". Thompson JC, Wood J, Feuer D (2007). "Prostate Cancer: Palliative Care and Pain Relief". Br Med Bull. 83: 341–354. doi:10.1093/bmb/ldm018. PMID 17628024.

Thompson, Wood & Feuer 2007, "Gastrointestinal symptoms". Thompson JC, Wood J, Feuer D (2007). "Prostate Cancer: Palliative Care and Pain Relief". Br Med Bull. 83: 341–354. doi:10.1093/bmb/ldm018. PMID 17628024.

Thompson, Wood & Feuer 2007, "General debility". Thompson JC, Wood J, Feuer D (2007). "Prostate Cancer: Palliative Care and Pain Relief". Br Med Bull. 83: 341–354. doi:10.1093/bmb/ldm018. PMID 17628024.

Thompson, Wood & Feuer 2007, "Lymphoedema". Thompson JC, Wood J, Feuer D (2007). "Prostate Cancer: Palliative Care and Pain Relief". Br Med Bull. 83: 341–354. doi:10.1093/bmb/ldm018. PMID 17628024.

Mundle, Afenya & Agarwal 2021, "Estimates of anxiety, depression, and distress". Mundle R, Afenya E, Agarwal N (September 2021). "The Effectiveness of Psychological Intervention for Depression, Anxiety, and Distress in Prostate Cancer: a Systematic Review of Literature". Prostate Cancer Prostatic Dis. 24 (3): 674–687. doi:10.1038/s41391-021-00342-3. PMID 33750905. S2CID 232325496.

Mundle, Afenya & Agarwal 2021, "Abstract". Mundle R, Afenya E, Agarwal N (September 2021). "The Effectiveness of Psychological Intervention for Depression, Anxiety, and Distress in Prostate Cancer: a Systematic Review of Literature". Prostate Cancer Prostatic Dis. 24 (3): 674–687. doi:10.1038/s41391-021-00342-3. PMID 33750905. S2CID 232325496.

Thompson, Wood & Feuer 2007, "Delirium". Thompson JC, Wood J, Feuer D (2007). "Prostate Cancer: Palliative Care and Pain Relief". Br Med Bull. 83: 341–354. doi:10.1093/bmb/ldm018. PMID 17628024.

Rebello et al. 2021, "Prognosis and survival". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Rebello et al. 2021, "Abstract". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Rebello et al. 2021, "Genetics". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Rebello et al. 2021, "Disease progression". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Sandhu et al. 2021, "The biology of prostate cancer". Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG (September 2021). "Prostate cancer". Lancet. 398 (10305): 1075–1090. doi:10.1016/S0140-6736(21)00950-8. PMID 34370973. S2CID 236941733.

Rebello et al. 2021, "Metastatic disease". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

Bergengren et al. 2023, "3.1 Epidemiology". Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. (May 2023). "2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review". Eur Urol. 84 (2): 191–206. doi:10.1016/j.eururo.2023.04.021. PMC 10851915. PMID 37202314. S2CID 258780321.

Pernar et al. 2018, "Risk factors for total prostate cancer". Pernar CH, Ebot EM, Wilson KM, Mucci LA (December 2018). "The Epidemiology of Prostate Cancer". Cold Spring Harb Perspect Med. 8 (12): a030361. doi:10.1101/cshperspect.a030361. PMC 6280714. PMID 29311132.

Rebello et al. 2021, "Genetic predisposition". Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. (February 2021). "Prostate cancer". Nat Rev Dis Primers. 7 (1): 9. doi:10.1038/s41572-020-00243-0. PMID 33542230. S2CID 231794303.

McHugh et al. 2022, "Introduction". McHugh J, Saunders EJ, Dadaev T, McGrowder E, Bancroft E, Kote-Jarai Z, et al. (June 2022). "Prostate Cancer Risk in Men of Differing Genetic Ancestry and Approaches to Disease Screening and Management in these Groups". Br J Cancer. 126 (10): 1366–1373. doi:10.1038/s41416-021-01669-3. PMC 9090767. PMID 34923574.

Pernar et al. 2018, "Risk factors for advanced and fatal prostate cancer". Pernar CH, Ebot EM, Wilson KM, Mucci LA (December 2018). "The Epidemiology of Prostate Cancer". Cold Spring Harb Perspect Med. 8 (12): a030361. doi:10.1101/cshperspect.a030361. PMC 6280714. PMID 29311132.

Pernar et al. 2018, "Statins". Pernar CH, Ebot EM, Wilson KM, Mucci LA (December 2018). "The Epidemiology of Prostate Cancer". Cold Spring Harb Perspect Med. 8 (12): a030361. doi:10.1101/cshperspect.a030361. PMC 6280714. PMID 29311132.

Pernar et al. 2018, "Exercise". Pernar CH, Ebot EM, Wilson KM, Mucci LA (December 2018). "The Epidemiology of Prostate Cancer". Cold Spring Harb Perspect Med. 8 (12): a030361. doi:10.1101/cshperspect.a030361. PMC 6280714. PMID 29311132.

Pernar et al. 2018, "Fish". Pernar CH, Ebot EM, Wilson KM, Mucci LA (December 2018). "The Epidemiology of Prostate Cancer". Cold Spring Harb Perspect Med. 8 (12): a030361. doi:10.1101/cshperspect.a030361. PMC 6280714. PMID 29311132.

Pernar et al. 2018, "Calcium, dairy products, and vitamin D". Pernar CH, Ebot EM, Wilson KM, Mucci LA (December 2018). "The Epidemiology of Prostate Cancer". Cold Spring Harb Perspect Med. 8 (12): a030361. doi:10.1101/cshperspect.a030361. PMC 6280714. PMID 29311132.

Bertoncelli Tanaka et al. 2022, "Conclusions". Bertoncelli Tanaka M, Sahota K, Burn J, Falconer A, Winkler M, Ahmed HU, et al. (January 2022). "Prostate Cancer in Transgender Women: What Does a Urologist Need to Know?". BJU Int. 129 (1): 113–122. doi:10.1111/bju.15521. PMID 34157213.

Bertoncelli Tanaka et al. 2022, "Interpretation of PSA in transgender women on GAHT". Bertoncelli Tanaka M, Sahota K, Burn J, Falconer A, Winkler M, Ahmed HU, et al. (January 2022). "Prostate Cancer in Transgender Women: What Does a Urologist Need to Know?". BJU Int. 129 (1): 113–122. doi:10.1111/bju.15521. PMID 34157213.

Bertoncelli Tanaka et al. 2022, "Screening for prostate cancer in transgender women". Bertoncelli Tanaka M, Sahota K, Burn J, Falconer A, Winkler M, Ahmed HU, et al. (January 2022). "Prostate Cancer in Transgender Women: What Does a Urologist Need to Know?". BJU Int. 129 (1): 113–122. doi:10.1111/bju.15521. PMID 34157213.

Lawrence W (1817). "Cases of Fungus Hæmatodes, with Observations, by George Langstaff, Esq. and an Appendix, Containing two Cases of Analogous Affections". Med Chir Trans. 8: 272–314. doi:10.1177/095952871700800114. PMC 2129005. PMID 20895322.

Adams J (1853). "The Case of Scirrhous of the Prostate Gland with Corresponding Affliction of the Lymphatic Glands in the Lumbar Region and in the Pelvis". Lancet. 1 (1547): 393–94. doi:10.1016/S0140-6736(02)68759-8.

Lytton 2001, p. 1859. Lytton B (June 2001). "Prostate cancer: a brief history and the discovery of hormonal ablation treatment". The Journal of Urology. 165 (6 Pt 1): 1859–1862. doi:10.1016/S0022-5347(05)66228-3. PMID 11371867.

Denmeade & Isaacs 2002, "Prostatectomy". Denmeade SR, Isaacs JT (May 2002). "A history of prostate cancer treatment". Nature Reviews. Cancer. 2 (5): 389–396. doi:10.1038/nrc801. PMC 4124639. PMID 12044015.

Walsh PC, Lepor H, Eggleston JC (1983). "Radical Prostatectomy with Preservation of Sexual Function: Anatomical and Pathological Considerations". The Prostate. 4 (5): 473–485. doi:10.1002/pros.2990040506. PMID 6889192. S2CID 30740301.

Denmeade & Isaacs 2002, "Radiation therapy". Denmeade SR, Isaacs JT (May 2002). "A history of prostate cancer treatment". Nature Reviews. Cancer. 2 (5): 389–396. doi:10.1038/nrc801. PMC 4124639. PMID 12044015.

Denmeade & Isaacs 2002, "Androgen-ablation therapy". Denmeade SR, Isaacs JT (May 2002). "A history of prostate cancer treatment". Nature Reviews. Cancer. 2 (5): 389–396. doi:10.1038/nrc801. PMC 4124639. PMID 12044015.

Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT, et al. (March 1982). "Tumor Growth Inhibition in Patients with Prostatic Carcinoma Treated with Luteinizing Hormone-Releasing Hormone Agonists". Proceedings of the National Academy of Sciences of the United States of America. 79 (5): 1658–1662. Bibcode:1982PNAS...79.1658T. doi:10.1073/pnas.79.5.1658. PMC 346035. PMID 6461861.

Denmeade & Isaacs 2002, "Cytotoxic chemotherapy". Denmeade SR, Isaacs JT (May 2002). "A history of prostate cancer treatment". Nature Reviews. Cancer. 2 (5): 389–396. doi:10.1038/nrc801. PMC 4124639. PMID 12044015.

Desai, McManus & Sharifi 2021, "Evolution of treatment". Desai K, McManus JM, Sharifi N (May 2021). "Hormonal Therapy for Prostate Cancer". Endocr Rev. 42 (3): 354–373. doi:10.1210/endrev/bnab002. PMC 8152444. PMID 33480983.

Teo, Rathkopf & Kantoff 2019, "Figure 1". Teo MY, Rathkopf DE, Kantoff P (January 2019). "Treatment of Advanced Prostate Cancer". Annu Rev Med. 70: 479–499. doi:10.1146/annurev-med-051517-011947. PMC 6441973. PMID 30691365.

Patel et al. 2020, p. 64. Patel MS, Halpern JA, Desai AS, Keeter MK, Bennett NE, Brannigan RE (May 2020). "Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis". Urology. 139: 64–70. doi:10.1016/j.urology.2019.11.062. PMID 32001306. S2CID 210982209.

McIntosh et al. 2023, Table 1. McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. (June 2023). "Global Funding for Cancer Research Between 2016 and 2020: a Content Analysis of Public and Philanthropic Investments". Lancet Oncol. 24 (6): 636–645. doi:10.1016/S1470-2045(23)00182-1. PMID 37269844.

McIntosh et al. 2023, Table 2. McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. (June 2023). "Global Funding for Cancer Research Between 2016 and 2020: a Content Analysis of Public and Philanthropic Investments". Lancet Oncol. 24 (6): 636–645. doi:10.1016/S1470-2045(23)00182-1. PMID 37269844.

Mai et al. 2022, "2.1 Human prostate cancer cell lines". Mai CW, Chin KY, Foong LC, Pang KL, Yu B, Shu Y, et al. (September 2022). "Modeling Prostate Cancer: What Does it Take to Build an Ideal Tumor Model?". Cancer Lett. 543: 215794. doi:10.1016/j.canlet.2022.215794. PMID 35718268. S2CID 249831438.

Mai et al. 2022, "2.4. Organoids". Mai CW, Chin KY, Foong LC, Pang KL, Yu B, Shu Y, et al. (September 2022). "Modeling Prostate Cancer: What Does it Take to Build an Ideal Tumor Model?". Cancer Lett. 543: 215794. doi:10.1016/j.canlet.2022.215794. PMID 35718268. S2CID 249831438.

Mai et al. 2022, "2.2 PDX lines". Mai CW, Chin KY, Foong LC, Pang KL, Yu B, Shu Y, et al. (September 2022). "Modeling Prostate Cancer: What Does it Take to Build an Ideal Tumor Model?". Cancer Lett. 543: 215794. doi:10.1016/j.canlet.2022.215794. PMID 35718268. S2CID 249831438.

Mai et al. 2022, "2.3 Genetically engineered mouse model (GEMM)". Mai CW, Chin KY, Foong LC, Pang KL, Yu B, Shu Y, et al. (September 2022). "Modeling Prostate Cancer: What Does it Take to Build an Ideal Tumor Model?". Cancer Lett. 543: 215794. doi:10.1016/j.canlet.2022.215794. PMID 35718268. S2CID 249831438.

Ittmann et al. 2013, "Introduction". Ittmann M, Huang J, Radaelli E, Martin P, Signoretti S, Sullivan R, et al. (May 2013). "Animal Models of Human Prostate Cancer: the Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee". Cancer Res. 73 (9): 2718–36. doi:10.1158/0008-5472.CAN-12-4213. PMC 3644021. PMID 23610450.

nih.gov

pubmed.ncbi.nlm.nih.gov

Brawley, Mohan & Nein 2018, "Radiation therapy". Brawley S, Mohan R, Nein CD (June 2018). "Localized Prostate Cancer: Treatment Options". American Family Physician. 97 (12): 798–805. PMID 30216009.

Thompson, Wood & Feuer 2007, "Delirium". Thompson JC, Wood J, Feuer D (2007). "Prostate Cancer: Palliative Care and Pain Relief". Br Med Bull. 83: 341–354. doi:10.1093/bmb/ldm018. PMID 17628024.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

Prostate cancer (English Wikipedia)

aacrjournals.org

cancerres.aacrjournals.org

aafp.org

cancer.net

cancer.org

cancerresearchuk.org

cdc.gov

doi.org

fda.gov

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

ncl.ac.uk

eprints.ncl.ac.uk

nice.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

prostatecanceruk.org

semanticscholar.org

api.semanticscholar.org

ucl.ac.uk

discovery.ucl.ac.uk

web.archive.org